Your Bio Repo Could Get You Fined. Here Is Why We Check Every Single One.
When a bio AI repository claims HIPAA compliance but the code says otherwise, the legal exposure falls on whoever deploys it. STEM-BIO-AI evaluated yorkeccak/bio — 322 stars, modern stack, one dangerous README line. Score: 48/100. T1 Quarantine. Full audit report with score matrix, regulatory traceability, and raw machine output.
Series
STEM_BIO_AI Audit ReportPart 2 of 2
We do something unusual at STEM-BIO-AI.
Every week, we pick a bio AI repository that looks impressive — good star count, clean README, modern stack — and we tear it apart. Not to be cruel. Because in bio AI, what a tool claims and what it actually does can be the difference between a research asset and a legal disaster.
This week, we opened a repository called Bio.
"The world's most powerful open-source bio AI assistant."
322 stars. 62 forks. PubMed. ClinicalTrials.gov. FDA DailyMed. ChEMBL.
Honestly? Impressive. The kind of tool we want to exist.
Then we read this line in the README:
"HIPAA-compliant architecture (when self-hosted)"
We looked at the code. Here is what self-hosted actually means in this repository:
- Auto-login as dev@localhost. No real authentication.
- Data stored in a local SQLite file. No access controls.
- Nothing logged. No audit trail.
- No Business Associate Agreement. No encryption layer. No breach notification process.
Evidence observed: README self-hosted section explicitly states "Mock Authentication" and "No authentication required." Local database behavior confirmed via SQLite configuration. No audit or logging surface identified in codebase.
HIPAA — Health Insurance Portability and Accountability Act, US federal law, 1996 — requires covered entities and their business associates to implement administrative, physical, and technical safeguards to protect electronic Protected Health Information (ePHI), including access controls, audit controls, risk analysis, and documented business associate arrangements (1). These are not optional baselines. They are the legal floor.
This repository meets none of them.
To be precise: the legal exposure does not fall on the repository itself. It falls on any organization that deploys this tool in a workflow involving real patient data and relies on this README claim to justify that deployment. That organization — whether a research lab, a clinic, or a startup — becomes the liable party. Under 2025 HHS enforcement figures, that exposure runs up to $73,011 per violation and $2,190,294 per year for willful neglect (1).
You think this is a rare edge case? The industry has a different answer.
These three cases are not analogies of identical systems. They are examples of one pattern: unverified security and compliance assumptions becoming institutional exposure.
Illumina developed genomic sequencing equipment deployed across hospitals and federal research agencies. According to the HHS Office of Inspector General, Illumina sold systems with cybersecurity vulnerabilities to federal agencies while representing compliance with government standards. A whistleblower alleged the vulnerabilities allowed unauthorized access to HIPAA-protected patient genomic data. The company settled False Claims Act allegations for $9.8 million in 2025 (2).
Enzo Biochem was one of the first biotech companies to go public. In April 2023, ransomware hit their systems. Clinical test data from 2.47 million individuals was accessed — Social Security numbers, test results, names. According to Reuters, investigators found shared credentials that had not been changed in years, no multi-factor authentication, and ineffective monitoring controls (3). Enzo paid $7.5 million to settle the class action and an additional $4.5 million to three state governments.
Then there is the case most people missed. Wisconsin Physicians Service, a government contractor handling Medicare claims, used a third-party file transfer tool. A breach occurred in May 2023. It went undetected for over a year. When finally discovered, 3.1 million individuals had been affected — including 946,801 current Medicare beneficiaries who were formally notified, with names, Social Security numbers, Medicare identifiers, and treatment dates exposed (4). The tool was trusted because it was widely used. No one ran an independent security review.
Three different organizations. Three different failure modes. One shared assumption: someone else already verified this.
No one had.
Stars Are Not Audits
A repository appears. Stars accumulate. The README sounds authoritative. Organizations deploy it because the star count signals community trust — not because anyone validated the compliance claims.
In bio AI, this is not just a bad habit. It is a mechanism for harm. Queries can involve real patient data. Clinical decisions. Research outcomes that affect real people. The gap between what a tool claims and what it does does not stay abstract for long.
We call this pattern AI slop: software whose surface claims are stronger than its implemented controls. Bio AI has more of it than most domains, because the domain sounds inherently serious — which makes the marketing language easier to believe and harder to question.
Three Checks Before You Deploy Any Bio AI Tool
See content credentials
1️⃣ read the implementation, not the README. Compliance claims live in code, configuration, and contracts — not in marketing copy.
2️⃣ run the tool through an AI slop detector. A high star count is social proof. It is not a security audit.
3️⃣ for anything touching health data, use STEM-BIO-AI. We check what the README does not say — compliance claims against actual implementation, reproducibility controls, data provenance, and clinical governance structure.
We publish one evaluation every Friday. The goal is not to tear down what people build. The goal is to make sure that what gets deployed does not quietly expose researchers, developers, and patients to damage nobody warned them about.
Bio law is not optional. It never was.
Want the full technical breakdown? The complete STEM-BIO-AI audit report — score matrix, stage-by-stage evidence, regulatory traceability, and raw machine output — is published at flamehaven.space.
STEM-BIO-AI | Weekly Repository Evaluation #1 | Every Friday
Next Friday: BioClaw — AI-Powered Bioinformatics Research Assistant on WhatsApp. 374 stars. Stanford. Princeton. A bioRxiv paper. And your genomic data passing through WhatsApp. We will look at where the data actually goes.
References
(1) U.S. HHS, HIPAA Security Rule and 2025 Inflation-Adjusted Civil Monetary Penalties. hhs.gov/hipaa — federalregister.gov
(2) HHS Office of Inspector General, Illumina Inc. settlement, 2025.
(3) Reuters, "Enzo Biochem to pay $4.5 mln for failing to safeguard patient data," August 2024.
(4) CMS, "CMS Notifies Individuals Potentially Impacted by Data Breach," 2024.
Next Step
If your AI system works in demos but still feels fragile, start here.
Flamehaven reviews where AI systems overclaim, drift quietly, or remain operationally fragile under real conditions. Start with a direct technical conversation or review how the work is structured before you reach out.
Direct founder contact · Response within 1-2 business days
Share
Continue the series
View all in seriesPrevious in STEM_BIO_AI Audit Report
STEM-BIO-AI Audit Report: yorkeccak/bio
Series continuation
This is currently the latest published entry.
Related Reading
Scientific & BioAI Infrastructure
STEM-BIO-AI Audit Report: yorkeccak/bio
Scientific & BioAI Infrastructure
Beyond Repo Scanning: How AIRI Expanded the Risk Vocabulary in STEM BIO-AI 1.7.x
Scientific & BioAI Infrastructure